Doctor talking with a patient about her lab results in the office

Your patient arrives at the appointment with their whole week logged

Morphi Professional is a new way to follow your patients’ treatment between appointments. With their permission, what they log in the app reaches you, organized for your decisions.

Morphi Professional starts in Brazil and is expanding to other countries. Join the list, and we’ll let you know when it reaches yours.

Join the list
Image by Drazen Zigic on Magnific

How it works

From your patient’s phone to your appointment

Today, what happens between appointments gets lost in messages, notes and the patient’s memory. With Morphi Professional, it reaches you organized.

  1. 01

    The patient logs

    Dose, symptoms, food and weight in the app, with a check-in that takes under a minute a day.

  2. 02

    They connect to your practice

    With your practice’s code and their permission, their journal starts reaching you.

  3. 03

    You follow along

    The summary ready before the appointment and, in between, how the treatment is going.

The app’s symptoms screen, with nausea, constipation and reflux this week
A real screen from the patient’s app, with a sample journal.

In your routine

Treatment in view, not just on appointment day

The evidence

What happens between appointments shows up in the outcome

Recent cohorts of patients on GLP-1 and GIP/GLP-1 treatment point the same way: engagement with digital follow-up goes hand in hand with greater weight loss and longer time on treatment.

  1. 1Johnson et al. · J Med Internet Res · 2026

    22.9%vs.17.5%

    weight loss at 12 months, engaged vs. non-engaged, and 2.88× the likelihood of passing 20%.

    Retrospective cohort · 126,553 adults · 12 months · UK

    See study details
    Result
    Adjusted weight loss of 22.9% among engaged users vs. 17.5% (difference 5.3 pp; Cohen’s d 0.54). Engaged users reached every threshold from 5% to 20% faster, and 16% vs. 5.6% passed 20% (risk ratio 2.88).
    What counted as engagement
    At least one coaching session, weekly weigh-ins and app use.
    Limitations
    Retrospective, from a single digital service whose staff wrote the paper. Only 5.3% met all three criteria.
    See the study ↗
  2. 2Johnson et al. · Diabetes Obes Metab · 2026

    21.5%vs.17.0%

    weight loss at 11 months, with thresholds reached faster and no excess adverse events.

    Retrospective cohort · 106,653 adults · 11 months · UK

    See study details
    Result
    Adjusted weight loss of 21.5% vs. 17.0% (4.5 pp). Thresholds from 5% to 25% were reached faster (HR 1.42 to 1.86), with no excess adverse events (IRR 0.83).
    What counted as engagement
    Coaching, weekly weigh-ins (4 or more a month) and another in-app interaction.
    Limitations
    Same service and same authors as study 1: not an independent confirmation.
    See the study ↗
  3. 3Tournayre et al. · J Med Internet Res · 2026

    79.5%vs.59.5%

    still on treatment at 48 weeks, most vs. least engaged with the digital assessment.

    Prospective cohort · 191 adults with BMI ≥ 40 · 48 weeks · Montpellier University Hospital, France

    See study details
    Result
    Persistence of 59.5%, 71.9% and 79.5% by engagement with the baseline digital assessment (adjusted OR 1.62 per level). Persistence accounted for about 69% of the association between engagement and weight loss.
    What counted as engagement
    Never used, partly used, or completed the validated questionnaires before starting.
    Limitations
    Single center and small sample; the direct effect of engagement on weight was not significant. One author holds shares in the platform, and the analysis was run by an independent statistician.
    See the study ↗

For your practice

A patient who stays on treatment stays with you

In study 3, those who engaged with the platform from the start stayed on treatment longer. For a practice, that’s continuity: it’s the patient who comes back for the next appointment instead of disappearing in between. That’s why, in Morphi Professional, a drop in use becomes an alert for you.

still on treatment at 48 weeks [3]

the most engaged
79.5%
those who never used the platform
59.5%
How to read these numbers, and references

How to read these numbers

These are observational studies: they show association, not causation. People who engage may be the ones who were already more motivated or more adherent to medication. All of them looked at other platforms, not Morphi, which doesn’t have its own outcome data yet.

References

  1. Johnson H, Clift AK, Reisel D, Huang D. J Med Internet Res. 2026;28:e83718. doi:10.2196/83718
  2. Johnson H, Clift AK, Reisel D, Huang DR. Diabetes Obes Metab. 2026;28(1):634-643. doi:10.1111/dom.70244
  3. Tournayre S, Bonnet JB, Anitcheou J, et al. J Med Internet Res. 2026;28:e80119. doi:10.2196/80119
  4. Talay L, Xu C, Alderete J, et al. Diabetes Obes Metab. 2026;28(11):9980-9990. doi:10.1111/dom.71181

Questions

What clinicians usually ask

What do I see about my patient?

With their permission, their app journal: doses, symptoms, check-ins, food, weight, measurements and labs. Their conversations with Morphi Intelligence stay on their phone.

Does Morphi prescribe or change the dose?

No. We don’t diagnose, recommend doses or change treatment. Morphi organizes the day to day and prepares the appointment; clinical decisions are yours.

Does Morphi Intelligence replace follow-up?

No, and the studies say the same: in an Australian service with 16,556 patients, an AI assistant alone didn’t improve adherence; cost, pauses and regular use mattered more. Morphi Intelligence organizes the week and prepares the appointment, and the care stays with you.

Is patient data secure?

It’s kept in a protected account, in a database in Brazil, and it’s never sold or used for advertising. Patients can download a copy or delete everything whenever they want. The details are in the Privacy Policy.

How much does it cost for a practice?

Plans are still being defined, and people on the list hear first.

When does Morphi Professional open?

No date yet. It starts in Brazil and expands to other countries. Join the list, and we’ll let you know when it opens in yours.

Be first in line

Join the list and be among the first to follow your patients with Morphi Professional when it opens in your country.

By sending this, you agree to hear from us about Morphi Professional, as described in our Privacy Policy.